期刊
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
卷 72, 期 1, 页码 175-180出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2014.10.016
关键词
addiction; basal cell carcinoma; Food and Drug Administration; melanoma; reclassification; squamous cell carcinoma; sunlamps; tanning beds; ultraviolet
类别
Tanning lamps have long been considered a class I medical device under regulation by the Food and Drug Administration (FDA). A growing body of research has repeatedly documented the association between elective indoor tanning and several negative health consequences. These accepted findings have prompted action by the FDA to officially reclassify tanning lamps as a class II medical device. The main purpose of this review is to update practitioners on the current state of tanning lamp classification and highlight the practical implications of this recent change. This information can be used by clinicians to easily reference this important action, and empower patients with a better understanding of the risks associated with indoor tanning.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据